Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Tools & Techniques Omics

Super Method Seeks Cancer's Kryptonite

| Jonathan James

The application of CRISPR on a genome-wide scale provides a major insight into tumor dependency.

Tools & Techniques Imaging

IVF ID

| Jonathan James

Artificial intelligence holds the key to improving embryo selection for in vitro fertilization.

Tools & Techniques Diagnostics & prognostics

PREDICTive Power

| Jonathan James

Prostate cancer prognosis presents a challenge – but a new algorithmic tool may help personalize predictions

Tools & Techniques Diagnostics & prognostics

Unlocking Serology’s Secrets

| Jonathan James

We explore the work of researchers aiming to revolutionize the diagnosis of fibromyalgia and cholera using blood-based technologies.

Research Field Animal models

Going out on a (Regrown) Limb

| Jonathan James

Meet the researchers uncovering the secrets of tissue regeneration.

Disease Area Pain & critical care

Painful Inequality?

| Jonathan James

How sex-dependent differences in molecular mechanisms could underpin men and women’s distinct experiences of chronic neuropathic pain.

Outside the Lab Public health

Picking up on the Subtler Signs of Brain Cancer

| Jonathan James

How early telltales of tumors are frequently missed by both patients and clinicians

Tools & Techniques Diagnostics & prognostics

Solving the Big Problems

| Luke Turner

We speak to bioengineer Stephen Quake to learn about the noninvasive prenatal tests that have saved thousands of pregnant women’s lives

Tools & Techniques Diagnostics & prognostics

An Inside Look at the CNS

| Danielle Fortuna, Mark Curtis

Neurological disorders can be invasive and time-consuming to diagnose, but profiling cytokines in the cerebrospinal fluid can lessen that burden

Tools & Techniques Diagnostics & prognostics

Seeing is Believing

| Jonathan James

Could changes in retinal blood vessels act as an early bio-marker for Alzheimer’s disease?

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register